TNFRSF4 and breast carcinoma: The genes corresponding to variants altered canonical pathways such as antigen presentation pathway and OX40 signaling pathway, indicating immune and inflammation response, as well as the tRNA charging pathway which was previously reported to be associated with breast cancer (42).